| Supper, Jochen (Genomatix Software 201211 Head Computational Biology) |
n. a. |
Genomatix Software (Group) |
Germany |
| Superti-Furga, Giulio (Austrian Academy of Sciences 201308 Director fo CeMM + Co-Founder of Proxygen) |
President/Director/Head Business Group/Unit/Division |
Austrian Academy of Sciences (ÖAW) |
Austria |
| Sunesson, Lovisa (Invest in Skane 201111 Business Developer) |
Business Development Manager / Strategy Manager |
Skåne (govt region) |
Sweden |
| Sundermann, Martin (Osborne Clarke 201612) |
Attorney / Lawyer |
Osborne Clarke (Group) |
Germany |
| Sun, Lanny (Full-Life Technologies 202211 CEO before Silicon Therapeutics 202008 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Full-Life Technologies (Group) |
China |
| Sumner, Lloyd (Univ Missouri 201806 Prof at UM at Columbia, MO) |
Professor |
University of Missouri System |
United States (USA) |
| Summerton, Linda (Immodulon Therapeutics 201702 CEO + TranScrip before Merck KGaA + AstraZeneca) |
Chief Executive Officer (CEO) |
|
|
| Sumeray (formerly Casse), Anna (Virometix 201902– CEO before Alacrita + BioVault + Ariad Europe + Novartis + ADL) |
Managing Partner |
Alacrita (Group) |
Switzerland |
| Sulzer, Philipp (Ionicon 201108 Science Manager) |
Researcher (industry) |
Ionicon (Group) |
Austria |
| Sultan, Maha (King Saud Univ 201112 Professor of Analytical Pharm. Chem.) |
Professor |
King Saud University (KSU) |
Saudi Arabia |
| Sullivan, Patrick J. (Consitution Medical Investors 201307 CEO + Co-founder before Cytyc Corp CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Sullivan, Elaine (Carrick Therapeutics 201501– CEO before Eli Lilly + Evotec 2015H1– Supervisory Board Member) |
Chief Executive Officer (CEO) |
Carrick Therapeutics (Group) |
Ireland, Republic of |
| Sujka, Sebastian (xbird 202101 CEO + Co-Founder) |
Managing Director |
Glooko (Group) |
Germany |
| Sugo, Tsukasa (GenAhead Bio 201810 CEO) |
Chief Executive Officer (CEO) |
GenAhead Bio Inc. (JP) |
Japan |
| Sudarskis, Alexandre (Neovii Pharmaceuticals AG 201707 CEO before Novartis Vaccines) |
Chief Executive Officer (CEO) |
Neopharm (IL) (Group) |
Switzerland |
| Suckau, Detlev (Bruker Corp 200803 Bruker Daltonics Head Proteomics RnD) |
Research & Development Manager |
Bruker (Group) |
Germany |
| Subramanian, Vandana (Sayre Therapeutics 201604 Head of Business Development) |
Business Development Manager / Strategy Manager |
Sayre Therapeutics Pvt. Ltd. |
India |
| Subramanian, Romesh (201904 CEO before RaNa Therapeutics + Alexion Pharmaceuticals) |
Chief Executive Officer (CEO) |
Dyne Therapeutics Inc. |
United States (USA) |
| Subkowski, Thomas (BASF 200808) |
n. a. |
BASF (Group) |
Germany |
| Su, Stanley (B Braun 201807 Managing Director Greater China) |
Managing Director |
B. Braun (Group) |
China |
| Su, Muh-Hwan (Sinopharm 201512 General Manager of SynCore Biotechnology Co Ltd) |
Chief Executive Officer (CEO) |
Sinphar Pharmaceutical (Group) |
Taiwan |
| Stölzle-Feix, Sonja (Nanion 201309 Senior Scientist) |
Researcher (industry) |
Nanion (Group) |
Germany |
| Stölzle, Ute (Genzyme 201011 Managing Director of Genzyme CEE GmbH) |
Managing Director |
Sanofi (Group) [since May 2011] |
Germany |
| Stölting, Michael (Nordrhein-Westfalen (govt) 202012 Management Board Member of NRW.Bank) |
Board member, executive |
Nordrhein-Westfalen (govt region) |
Germany |
| Stöhr, Thomas (A2M Pharma GmbH 201104 Managing Director) |
Managing Director |
A2M Pharma GmbH |
Germany |
| Stöckl, Petra (Tirol (govt) 201105 Standortagentur Tirol Programme Manager Life Sciences) |
Business Development Manager / Strategy Manager |
Life Sciences Tirol (Cluster) |
Austria |
| Stöckl, Lars (FyoniBio 202204 Managing Director) |
Managing Director |
Canton Biologics (Group) |
Germany |
| Stöcker, Winfried (Euroimmun 201007 CEO) |
Chief Executive Officer (CEO) |
PerkinElmer (Group) |
Germany |
| Stöckemann, Klaus (Peppermint 200905 Managing Partner before 3i Deutschland before Schering + Asta Medica) |
Managing Partner (investment firm) |
Peppermint (Group) |
Germany |
| Stähler, Peer (febit biotech GmbH 200512) |
n. a. |
Hummingbird Diagnostics GmbH |
Germany |
| Stähler, Cord F. (febit 200401 CEO) |
Chief Executive Officer (CEO) |
febit (Group) |
Germany |
| Stäheli, Michael (PolyPeptide 202305 Head of IR + Corp Communications) |
Managing Director |
|
|
| Stüttgen, Marcus (JnJ 201309 Director New Business Development at Janssen-Cilag GmbH) |
Business Development Manager / Strategy Manager |
Johnson & Johnson (JnJ) (Group) |
Germany |
| Stünkel, Klaus G. E. (ProBioGen 200708– VP BusDev Licensing before Bayer AG) |
Business Development Manager / Strategy Manager |
Minapharm (Group) |
Germany |
| Stührk, Olaf (Commerzbank Berlin) |
n. a. |
Commerzbank (Group) |
Germany |
| Stübler, Hermann (Bayer 201606 Head of Weed Contral Research) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Stübiger, Gerald (Medical Univ Vienna 201208 Institut für Gefäßbiologie + Thromboseforschung) |
Researcher (university / research institute) |
Medical University of Vienna (MedUni Wien) |
Austria |
| Stutz, Deborah (Sigma-Aldrich 201410 Director Biopharma Marketing) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
United States (USA) |
| Sturmhoefel, Knut (Novartis 201511 Head BD&L Ophthalmology + Respiratory) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
| Sturm, Stephan (Fresenius 202205 Supervisory Board Chair of Fresenius Medical Care Management + CEO of Fresenius) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
|
| Sturm, Andre (Vertama 202307 CEO + Founder) |
Managing Director |
Vertama GmbH (formerly UG) |
Germany |
| Sturge, Simon (Kymab 201905– CEO before Merck (DE) + Boehringer + OctoPlus + Vernalis + Celltech) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Stumbaum, Mihaela (Univ Konstanz) |
Researcher (university / research institute) |
University of Constance (Universität Konstanz) |
Germany |
| Stukkens, Guy (Analis SA 201212 CEO) |
Chief Executive Officer (CEO) |
Analis S.A. |
Belgium |
| Stuhler, Gernot (Cherry Biolabs 202011 CEO + Founder + Prof at Univ Hospital Würzburg) |
Chief Executive Officer (CEO) |
Cherry Biolabs GmbH |
Germany |
| Stuge, Örn (Aleva Neurotherapeutics 201108 Chairmen Board of Directors) |
Board member, non-executive |
Aleva Neurotherapeutics S.A. |
Switzerland |
| Stuber, Werner (BMD GmbH before BIO Mitteldeutschland 200810) |
Business Development Manager / Strategy Manager |
BMD Life Sciences GmbH |
Germany |
| Stubbers, Ron (InGeneron 201710 Head of Operations) |
Chief Operating Officer (COO) |
InGeneron (Group) |
Germany |
| Stuart, Martin (Definiens 201201– EVP + General Manager North America + Asia Pacific before Aperio + Entropia) |
Regional manager |
AstraZeneca (Group) |
Germany |
| Stuart, Lynda (Gates Foundation 201909 Deputy Director Vaccines + Human Immunobiology, Discovery + Translational) |
n. a. |
GATES Group (family of Bill Gates) |
United States (USA) |
| Stuart, Edward (HS Life Sciences 200901 CEO + founder before Neurimmune 200712 CEO before U3 Pharma AG before DeveloGen) |
Chief Executive Officer (CEO) |
HS LifeSciences (Group) |
Switzerland |
| Ströver, Rebekka (Leukocare 202103 Specialist Communications + Marketing) |
Public Relations Manager / Investor Relations Manager |
Leukocare (Group) |
Germany |
| Strüngmann, Thomas (Hexal founder + Biotech investor) |
Company Founder |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Strüngmann, Andreas (Hexal founder + Biotech investor) |
Company Founder |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Struhalla, Marc (c-LEcta GmbH 201105 Managing Director) |
Managing Director |
Kerry Group (Group) |
Germany |
| Struckmeyer, Thomas (EW Group 202012– CEO at BioCheck BV before IdentiGEN) |
Chief Executive Officer (CEO) |
EW Group (Erich Wesjohann) (Group) |
Netherlands |
| Strube, Randy (InSphero 201401– Director of Global Marketing) |
Sales Manager / Marketing Manager |
InSphero (Group) |
Switzerland |
| Strub, Oliver (Santhera 201502– appointed General Counsel + Board Secretary) |
General Counsel / Chief Legal Officer (CLO) |
Santhera (Group) |
Switzerland |
| Stropoli, Giovanni (Santhera 201502– Chief Commercial Officer before InterMune) |
Chief Commercial Officer (CCO) |
Santhera (Group) |
Switzerland |
| Strom, Antje (KPMG 201608 Partner) |
consulting (economic) |
KPMG (Group) |
Germany |
| Strohmenger, Rainer (Wellington Partners Venture Capital 201303 General Partner) |
General Partner (venture partner) |
Wellington Partners (Group) |
Germany |
| Strohmeier, Fred (Agilent 201312– SVP + President Life Sciences + Dx business RETIRED 2015) |
President/Director/Head Business Group/Unit/Division |
Agilent (Group) |
United States (USA) |
| Stroehlein, Guido (ChromaCon 201109 CEO) |
Chief Executive Officer (CEO) |
ChromaCon AG |
Switzerland |
| Strode, Pamela (Fulcrum Therapeutics 201909– SVP Regulatory Affairs + Quality Assurance before Epizyme + BMS + BI |
Regulatory Affairs Manager |
Fulcrum Therapeutics Inc. (Nasdaq: FULC) |
United States (USA) |
| Strobl, Wolfram (Fresenius 201703 General Manager at Fresenius Medical Care Adsorber Tec GmbH) |
General Manager (management) |
Fresenius (Group) |
Germany |
| Strigini, Bruno (Novartis 201605–201801 Head Oncology Business Unit RETIRED 1/18 joined 2014 from Merck & Co) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Striggow, Frank (Life Science Inkubator 201802 COO before KeyNeuroTek 200006– CEO) |
Chief Operating Officer (COO) |
Life Science Inkubator GmbH (LSI) |
Germany |
| Strek, Harry (Bayer 201411 Head of Bayer CropScience Weed Resistance Competence Center Ffm) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Streimelweger, Thomas (red-strars.com data 201908 CEO) |
Chief Executive Officer (CEO) |
red-stars.com data AG |
Austria |
| Streibel, Lennart (Centogene 202202 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Centogene (Group) |
Netherlands |
| Straus, Joseph |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Straubinger, Helmut J. (Tricares 201603–2024032 CEO formerly JenaValve 200709 CEO RETIRED 3/24) |
Chief Executive Officer (CEO) |
Tricares (Group) |
France |
| Stratton, Tim (Thermo Fisher 201506 Manager Library Technologies) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
| Stratton, Kim (Centogene 202202– CEO before Orphazyme + Shire Pharmaceuticals + Novartis) |
Chief Executive Officer (CEO) |
Centogene (Group) |
Netherlands |
| Stratmann, Martin (Max Planck 201406– President of Max Planck Society before Director at MPI für Eisenforschung) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
Germany |
| Stratford, Richard (OncoImmunity AS 201812 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
NEC (Group) |
Norway |
| Strasser, Ruth |
n. a. |
University of Dresden |
Germany |
| Strasser, Ralf (Dynamic Biosensors 202209 COO + Co-Founder) |
Chief Operating Officer (COO) |
Dynamic Biosensors (Group) |
Germany |
| Stragier, Patrick (Promethera 201512– VP Operations before Solvay + DSM Biologics + Genzyme + Lonza + MaSTherCell) |
Chief Operating Officer (COO) |
Promethera (Group) |
Belgium |
| Stout, Katja (Scius Communications 201808– before LifeSci London + Citigate Dewe Rogerson + Northbank Communications) |
Public Relations Manager / Investor Relations Manager |
Scius Communications (GB) |
United Kingdom (GB) |
| Stoten, Adam (Isis Innovation 200509) |
IP Manager |
University of Oxford |
United Kingdom (GB) |
| Stormorken, Pål O. (Yara 201702 Head of Application + Crop Management Systems) |
President/Director/Head Business Group/Unit/Division |
Yara (Group) |
Norway |
| Storm, Detlef (Becton Dickinson 201304 Marketing Manager Central Europe at BD Diagnostics Heidelberg) |
Sales Manager / Marketing Manager |
Becton, Dickinson (Group) |
Germany |
| Storck, Thorsten (Gentana 200407–) |
n. a. |
Gentana GmbH |
Germany |
| Stoops, Sooike (VIB 201704 Expert Press + Public Communications) |
Public Relations Manager / Investor Relations Manager |
VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie) |
Belgium |
| Stonehouse, Jon P. (BioCryst 200902 CEO before Merck KGaA) |
Chief Executive Officer (CEO) |
BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) |
United States (USA) |
| Stone, Adam (Perceptive Advisors 202003 Chief Investment Officer) |
Investment Manager |
Perceptive Advisors LLC |
United States (USA) |
| Stoller, Anne-Kathrin (Bachem 201203 VP Marketing + Sales) |
Sales Manager / Marketing Manager |
Bachem (Group) |
Switzerland |
| Stolle, Katja (Messe München 201202– interim Exhibition Director Analytica) |
Product Manager (personnel) |
Messe München GmbH |
Germany |
| Stoll, Norbert (Analytical Instrument GmbH 201103 Managing Director) |
Managing Director |
Analytical Instrument GmbH (AIG) |
Germany |
| Stoll, Dwight (Gastavus Adolphus College, Minnesota 201704 Associate Professor) |
Professor |
|
|
| Stolberg, Nikolaus Graf (Medac 201703 Managing Director) |
Managing Director |
Medac Gesellschaft für klinische Spezialpräparate mbH |
Germany |
| Stojanov, Tomas (Genea Biomdex 201505 CEO) |
Chief Executive Officer (CEO) |
Genea Biomedx (AU) |
Australia |
| Stoffelen, Richard (Centogene 201805 CFO) |
Chief Financial Officer (CFO) |
Centogene (Group) |
Germany |
| Stoffel, Stefan (Lonza 201903– COO of Lonza Pharma Biotech & Nutrition segment joined 1991) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Stoffel, Ruedi (Roche 201210 Head of Custom Biotech) |
n. a. |
Roche (Group) |
Germany |
| Stoffel, Boris (Miltenyi Biotec 201301 CEO before Memorec Stoffel) |
Managing Director |
Miltenyi Biotec (Group) |
Germany |
| Stoekli, Markus (Novartis 201606 Novartis Instituts for BioMedical Research) |
Researcher (industry) |
Waters (Group) |
United States (USA) |
| Stocker, Andreas (Biomeva GmbH 201305 Director of Business Development) |
Business Development Manager / Strategy Manager |
Asahi Glass (AGC) (Group) |
Germany |
| Stock, Sabrina (Eppendorf 202105 PR) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 13 14 15 ... 88 89 90 
Person
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
